Clinical Trial Update: A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the safety of combining sirolimus (albumin-bound) with palbociclib and fulvestrant in patients with advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Palbociclib (palbociclib)
• Sirolimus (Albumin-Bound) (sirolimus)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING